234 results
Page 3 of 12
8-K
EX-99.1
7ggrpcf3ecv
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm
8-K
EX-99.1
avdmmfoy
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-10.1
swk955
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-10.1
mq92lh2j 1ggk3
12 Feb 21
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
5:09pm
424B5
hukxy31q3w4imb
12 Feb 21
Prospectus supplement for primary offering
12:00am
S-3ASR
EX-4.6
ohi15rh3
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
w07yi
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.5
e0n3f3jryw2
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-5.1
nh8be6l
10 Feb 21
Automatic shelf registration
6:04am
8-K
EX-99.2
1gt dguuy0x
8 Feb 21
Regulation FD Disclosure
4:09pm
8-K
EX-3.1
hcil3 vovua2
11 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:43pm
424B5
lf44k2vky4ffbz
16 Nov 20
Prospectus supplement for primary offering
12:21pm
8-K
EX-1.1
x9t qztcjz48m
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
424B5
8e9mjbm3j4ybckaoluf
12 Nov 20
Prospectus supplement for primary offering
4:57pm